U.S. in Vitro Fertilization Market 2025 | Development, Trends, Demand and Forecast Till 2033

United States In Vitro Fertilization Market Overview

Market Size in 2024: USD 161 Million

​Market Forecast in 2033:  USD 385.6 Million

Market Growth Rate: 9.1% (2025-2033)

According to the latest report by IMARC Group, the in-vitro fertilization market size in the U.S. was valued at USD 161 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 385.6 Million by 2033, exhibiting a CAGR of 9.1% from 2025-2033. The market is on the rise due to several key factors. One major contributor is the increasing occurrence of infertility among couples, linked to changing lifestyles, delayed parenthood, and underlying health conditions.

United States In Vitro Fertilization Industry Trends and Drivers:

The U.S. in vitro fertilization (IVF) market is undergoing significant growth as more individuals and couples turn to assisted reproductive technologies to achieve their family-building goals. Rising healthcare awareness, coupled with advancements in reproductive technologies, has made IVF a popular choice for many. Key drivers of this growth include an increase in infertility cases due to factors such as obesity, diabetes, and polycystic ovary syndrome (PCOS), alongside an overall shift in societal attitudes toward family planning. As lifestyle changes contribute to a higher prevalence of chronic diseases, there is a corresponding rise in the demand for fertility treatments, particularly IVF, which provides hope to those struggling to conceive. Technological innovations, such as genetic testing and embryo screening, are further enhancing IVF success rates, providing couples with more personalized, effective treatments. This makes IVF an increasingly viable and attractive option for those facing fertility challenges, contributing to the continued expansion of the market.

One of the most significant factors influencing the IVF market in the U.S. is the development of advanced technologies that are enhancing the efficiency and outcomes of IVF procedures. Innovations in genetic testing, such as preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD), have become integral to IVF cycles. These tests allow for the identification of genetic conditions before implantation, helping to reduce the risk of inherited diseases and increasing the likelihood of a successful pregnancy. Furthermore, improvements in embryo culture and cryopreservation techniques are allowing fertility clinics to offer better success rates with fewer cycles, providing a more cost-effective solution for patients. As IVF technology continues to advance, procedures are becoming more tailored to individual needs, increasing accessibility and improving overall patient satisfaction. The growth of IVF clinics across the country, with expanded offerings in services such as egg freezing, surrogacy, and egg donation, is also helping to meet the diverse needs of patients, ensuring that IVF remains a key part of the broader reproductive healthcare landscape.

Looking ahead, the U.S. IVF market is expected to continue expanding due to a combination of demographic shifts and increasing healthcare investments. The growing acceptance of fertility treatments, particularly IVF, among individuals and couples who delay childbearing due to career or lifestyle choices, is a contributing factor to this trend. The availability of a wide range of IVF services – from basic procedures to highly specialized treatments – is making these services more accessible to a larger segment of the population. Additionally, ongoing research into new techniques and improved patient care, including advancements in the freezing and storage of eggs and embryos, further enhances the success rates of IVF. The fertility treatment landscape is also being positively impacted by increasing insurance coverage for IVF, which is helping to reduce the financial burden associated with these procedures. As the demand for IVF continues to rise, fertility clinics and healthcare providers are poised to leverage emerging technologies and offer more comprehensive care, ensuring that assisted reproductive services remain at the forefront of modern healthcare.

Key Drivers of Market Growth:

• Rising Prevalence of Chronic Diseases: Conditions like obesity, diabetes, and PCOS, which are associated with infertility, are driving the demand for IVF as a solution.
• Technological Innovations: Advancements in genetic testing, embryo screening, and cryopreservation techniques are improving the success rates of IVF, making it a more viable option for patients.
• Changing Attitudes Toward Family Planning: With delayed childbearing becoming more common, there is a growing demand for assisted reproductive technologies, including IVF, as individuals and couples seek to overcome fertility challenges.
• Improved Access and Affordability: As IVF procedures become more widely available and insurance coverage expands, IVF is becoming more accessible to a broader range of individuals and families.
• Expanded Service Offerings: Fertility clinics are diversifying their services, including offering egg freezing, egg donation, and surrogacy, catering to an increasingly diverse population of patients.

In conclusion, the U.S. IVF market is on a promising trajectory, driven by a combination of medical advancements, increasing demand for fertility treatments, and changing societal norms. As technological innovations continue to improve the efficiency and success rates of IVF procedures, more individuals and couples are turning to this method to fulfill their family aspirations. The future of the IVF market looks bright, with continued growth expected in response to rising chronic disease rates, enhanced patient care, and greater access to fertility services. With ongoing research and development, the IVF market will continue to evolve, providing hope and solutions to a growing number of people seeking to navigate the challenges of infertility. As awareness and acceptance of IVF continue to rise, the U.S. market will remain at the forefront of reproductive healthcare, offering groundbreaking options for those looking to start or expand their families.

United States In Vitro Fertilization Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Reagent
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Instrument
  • Imaging Systems
  • Incubators
  • Cryosystems
  • IVF Cabinet
  • Ovum Aspiration Pump
  • Sperm Separation Systems
  • Micromanipulator Systems
  • Others
• Accessories

Procedure Type Insights:

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

Cycle Type Insights:

• Conventional IVF
• IVF with ICSI
• IVF with Donor Eggs

End User Insights:

• Fertility Clinics
• Hospitals
• Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=19063&flag=F

Browse more research report:

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145